The Law Office of Joseph Klein is Investigating Possible Breaches of Fiduciary Duty by the Board of Genoptix, Inc. in Connect...
26 Enero 2011 - 5:45PM
Business Wire
The Law Office of Joseph Klein is investigating the Board of
Directors of Genoptix, Inc. (Nasdaq: GXDX) for possible breaches of
fiduciary duty and other violations of state law in connection with
the sale of the Company to Novartis AG (“Novartis”) (NYSE: NVS).
Under the terms of the transaction, Genoptix shareholders will
receive $25.00 cash for each share of Genoptix common stock they
own, for a total transaction value of approximately $470
million.
The investigation concerns whether the Genoptix Board of
Directors breached their fiduciary duties to Genoptix stockholders
by failing to adequately shop the Company before entering into this
transaction and whether Novartis is underpaying for Genoptix
shares. At least one analyst set a price target of $28.00 per share
and Genoptix stock traded as high as $38.79 per share as recently
as April 30, 2010.
If you own common stock in Genoptix and wish to obtain
additional information, please contact Joseph Klein, Esq. directly,
via email at jk@jkleinlawfirm.com, by telephone at 718-947-0005,
Toll Free: 877-STOK-180, or visit
http://www.jkleinlawfirm.com/genoptix-gxdx.html.
Joseph Klein, Esq. is an experienced attorney and has also
practiced as a Certified Public Accountant. Mr. Klein represents
investors and participates in securities litigations involving
financial fraud throughout the nation. Attorney advertising. Prior
results do not guarantee similar outcomes.
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
Genoptix, Inc. (MM) (NASDAQ:GXDX)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024
Real-Time news about Genoptix, Inc. (MM) (NASDAQ): 0 recent articles
Más de The Law Office of Joseph Klein Artículos de Noticias